Northwestern Mutual Wealth Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
Northwestern Mutual Wealth Management's HQL Position: Q3 2026 in Review
Northwestern Mutual Wealth Management increased its abrdn Life Sciences Investors (HQL) stake by 222% in Q3 2026, buying an estimated $52.4K and bringing the position to 3,757 shares worth $70.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2446.
Northwestern Mutual Wealth Management first reported a position in HQL in Q4 2015 and has held it in 16 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q3 2026.
- Northwestern Mutual Wealth Management held 3,757 shares of abrdn Life Sciences Investors worth $70.3K as of Q3 2026.
- Northwestern Mutual Wealth Management bought 2,589 abrdn Life Sciences Investors shares in Q3 2026, an estimated $52.4K.
- abrdn Life Sciences Investors made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q3 2026, its #2446 holding.
- Northwestern Mutual Wealth Management first reported a position in abrdn Life Sciences Investors in Q4 2015 and has held it in 16 quarters since.
- 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.